181 related articles for article (PubMed ID: 10102015)
1. [Modified triple therapies for Helicobacter pylori eradication].
Nguyen HN; Matern S
Dtsch Med Wochenschr; 1999 Mar; 124(9):271. PubMed ID: 10102015
[No Abstract] [Full Text] [Related]
2. [Importance of ranitidine in the eradication of Helicobacter pylori].
Beglinger C
Rev Med Suisse Romande; 1995 Oct; 115(10):795-7. PubMed ID: 7501932
[No Abstract] [Full Text] [Related]
3. [Leaving Helicobacter pylori no chance. Triple therapy should consider resistance status].
MMW Fortschr Med; 2005 May; 147(20):52. PubMed ID: 15957863
[No Abstract] [Full Text] [Related]
4. [Therapy of Helicobacter pylori infection].
Treiber G
Praxis (Bern 1994); 2000 May; 89(22):958-62. PubMed ID: 10893994
[TBL] [Abstract][Full Text] [Related]
5. Management of Helicobacter pylori-positive peptic ulcer disease.
Malfertheiner P
Scand J Gastroenterol Suppl; 1996; 215():69. PubMed ID: 8722386
[No Abstract] [Full Text] [Related]
6. Helicobacter pylori eradication in peptic dyspepsia.
Lule GN
East Afr Med J; 2005 Dec; 82(12):601-2. PubMed ID: 16619702
[No Abstract] [Full Text] [Related]
7. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
Leodolter A; Peitz U; Malfertheiner P
Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
[TBL] [Abstract][Full Text] [Related]
8. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
[TBL] [Abstract][Full Text] [Related]
9. [Methods for increasing the efficacy and safety of Helicobacter pylori eradication regimens].
Zakharova NV
Eksp Klin Gastroenterol; 2006; (4):59-66. PubMed ID: 17269426
[No Abstract] [Full Text] [Related]
10. Treatment of Helicobacter pylori infection.
Ebell MH
J Fam Pract; 1996 Jun; 42(6):568. PubMed ID: 8656165
[No Abstract] [Full Text] [Related]
11. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of Helicobacter pylori positive ulcer--the search for simple and effective therapy].
Eliakim R; Rachmileweitz D
Harefuah; 1996 Nov; 131(10):405-6. PubMed ID: 8981820
[No Abstract] [Full Text] [Related]
14. [Methods to optimize the management of Helicobacter pylori infection. The comparative efficacy of the triple and quadruple therapy used as a first line therapy].
Grigor'ev PIa; Iakovenko AV; Iakovenko EP; Vasil'ev IV; Komleva IuV; Oprishchenko IV; Aldiiarova MA
Eksp Klin Gastroenterol; 2004; (5):31-8, 148. PubMed ID: 15770858
[TBL] [Abstract][Full Text] [Related]
15. [Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients].
Søndergaard B; Bytzer P
Ugeskr Laeger; 2005 Jan; 167(5):500-2. PubMed ID: 15745170
[No Abstract] [Full Text] [Related]
16. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome.
Wheeldon TU; Hoang TT; Phung DC; Björkman A; Granström M; Sörberg M
Aliment Pharmacol Ther; 2005 Apr; 21(8):1047-53. PubMed ID: 15813841
[TBL] [Abstract][Full Text] [Related]
18. [Diagnosis and treatment of Helicobacter pylori infection. Its relationship with gastrointestinal ulcer and antimicrobial resistance].
Antelo P; Almuzara M; Avagnina A; Topor J; Barberis C; Barcia T; Araujo G; Vay C; Famiglietti A
Medicina (B Aires); 2001; 61(5 Pt 1):545-51. PubMed ID: 11721321
[TBL] [Abstract][Full Text] [Related]
19. [The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori].
Grigor'ev PIa; Isakov VA; Iakovenko EP; Soluianova IP
Ter Arkh; 1992; 64(8):101-4. PubMed ID: 1440381
[No Abstract] [Full Text] [Related]
20. "Modern therapies for Helicobacter pylori infection".
Go MF
Acta Gastroenterol Latinoam; 1996; 26(2):119-23. PubMed ID: 9137668
[No Abstract] [Full Text] [Related]
[Next] [New Search]
